Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
THEMIS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FBN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CHL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728730 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PKD1L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KSR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASSF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PELI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on